Skip to main content
Clinical Trials/NCT02298270
NCT02298270
Completed
Not Applicable

Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype

Massachusetts General Hospital1 site in 1 country65 target enrollmentMarch 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Neurofibromatosis
Sponsor
Massachusetts General Hospital
Enrollment
65
Locations
1
Primary Endpoint
Quality of Life (WHOQOL-BREF)
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

This study tests the efficacy of an 8-week, Skype-based, group resiliency training intervention (The Relaxation Response Resiliency Program) for improving psychological stress in patients with Neurofibromatosis. A control group will receive a general health education curriculum. The investigators hypothesize that patients will improve on measures of psychological stress as a result of the resiliency program.

A substudy (Unique Protocol ID: 2013P002605b) has been approved to test this study on a sub-population: patients with NF2 who are hard of hearing.

Registry
clinicaltrials.gov
Start Date
March 2014
End Date
July 2015
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ana-Maria Vranceanu, PhD

Dr.

Massachusetts General Hospital

Eligibility Criteria

Inclusion Criteria

  • Age 18 or older
  • Can read and speak English at or above the 6th grade level
  • Diagnosis of neurofibromatosis type 1, neurofibromatosis type 2, or schwannomatosis

Exclusion Criteria

  • Severe active or untreated major mental illness that would interfere with study participation, to be determined at the discretion of the study investigator (e.g. untreated psychosis or suicidality)
  • Recent (within past 3 months) change in antidepressant medication
  • Use of formal relaxation training (including past participation in a mind-body program), currently or in the past 6 months.
  • Unable or unwilling to sign the informed consent documents
  • Unable or unwilling to complete psychological assessments online via the REDCap system.
  • Unable or unwilling to participate in an intervention delivered via videoconferencing with Skype.

Outcomes

Primary Outcomes

Quality of Life (WHOQOL-BREF)

Time Frame: Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

The WHOQOL-BREF comprises of 26 items which measure the following broad domains: physical health, psychological health, social relationships, and environment. The WHOQOL-BREF is a shorter version of the original instrument that may be more convenient for use in large research studies or clinical trials.

Satisfaction with Life (SWL)

Time Frame: Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

The Satisfaction with Life (SWL) scale is a reliable and valid 5-item self-report measure of global life satisfaction. Responses are made on a 7-point scale with higher scores reflecting higher life satisfaction.

Secondary Outcomes

  • Patient Health Quesionnaire (PHQ)(Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32))
  • The Pain Catastrophizing Scale (PCS)(Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32))
  • Cognitive and Affective Mindfulness Scale (CAMS)(Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32))
  • Perceived Stress Scale (PSS-10)(Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32))
  • Interpersonal Reactivity Index (IRI)(Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32))
  • Measure of Current Status (MOCS-A)(Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32))
  • The Gratitude Questionnaire (GQ-6)(Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32))
  • Functional Assessment of Chronic Illness Therapy- Fatigue Scale (FACIT-Fatigue)(Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32))
  • Medical Outcomes Study (MOS) Social Support Survey(Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32))
  • The 14-Item Resiliency Scale (RS-14)(Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32))
  • Pain Numerical Rating Scale (Pain NRS)(Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32))
  • Life Orientation Test (LOT) Optimism Scale(Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32))
  • Functional Assessment of Chronic Illness Therapy- Spirituality Scale (FACIT-Sp)(Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32))
  • Brief Pain Inventory (BPI)(Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32))
  • Posttraumatic Growth Inventory (PGI)(Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32))
  • Distress Analogue Scales(Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32). Also administered at mid-interevention, before each group session.)
  • Epworth Sleepiness Scale (ESS)(Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32))

Study Sites (1)

Loading locations...

Similar Trials